Denise Dignam - 08 May 2024 Form 4 Insider Report for Chemours Co (CC)

Role
President & CEO, Director
Signature
/s/ Nicole Perez Lengel, Attorney-in-Fact
Issuer symbol
CC
Transactions as of
08 May 2024
Net transactions value
$0
Form type
4
Filing time
10 May 2024, 16:04:12 UTC
Previous filing
03 Apr 2024
Next filing
03 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CC Common Stock Award $0 +34,431 +84% $0.000000 75,328 08 May 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CC Stock Option (Right to Buy) Award $0 +92,108 $0.000000 92,108 08 May 2024 Common Stock 92,108 $27.50 Direct F3
transaction CC Performance Stock Option (Right to Buy) Award $0 +95,792 $0.000000 95,792 08 May 2024 Common Stock 95,792 $30.25 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025.
F2 Includes directly owned shares, restricted stock units and dividend equivalent units.
F3 These options are scheduled to vest in three equal annual installments beginning on May 8, 2025.
F4 Represents a 10 percent premium above the closing price of the Company common stock on the date of grant.